Found: 6
Select item for more details and to access through your institution.
Long‐term and low‐dose rituximab treatment for chronic inflammatory demyelinating polyneuropathy.
- Published in:
- Journal of the Peripheral Nervous System, 2024, v. 29, n. 3, p. 350, doi. 10.1111/jns.12653
- By:
- Publication type:
- Article
Bone Marrow Mesenchymal Stem Cell Exosome Attenuates Inflammasome-Related Pyroptosis via Delivering circ_003564 to Improve the Recovery of Spinal Cord Injury.
- Published in:
- Molecular Neurobiology, 2022, v. 59, n. 11, p. 6771, doi. 10.1007/s12035-022-03006-y
- By:
- Publication type:
- Article
Effect of fasudil on experimental autoimmune neuritis and its mechanisms of action.
- Published in:
- Brazilian Journal of Medical & Biological Research, 2020, v. 53, n. 1, p. 1, doi. 10.1590/1414-431X20198669
- By:
- Publication type:
- Article
Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 9, p. 4288, doi. 10.1007/s00415-023-11759-2
- By:
- Publication type:
- Article
Insights into refractory chronic inflammatory demyelinating polyneuropathy: a comprehensive real-world study.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1326874
- By:
- Publication type:
- Article
MiR-487b suppressed inflammation and neuronal apoptosis in spinal cord injury by targeted Ifitm3.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 7, p. 2405, doi. 10.1007/s11011-022-01015-3
- By:
- Publication type:
- Article